Get the Stockscreener App
0.5994
0.10%
-0.0006
After Hours:
.59
-0.0094
-1.57%
Autonomix Medical Inc stock is traded at $0.5994, with a volume of 76,053.
It is down -0.10% in the last 24 hours and down -10.54% over the past month.
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
See More
Previous Close:
$0.60
Open:
$0.61
24h Volume:
76,053
Relative Volume:
0.02
Market Cap:
$13.59M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.12%
1M Performance:
-10.54%
6M Performance:
-80.15%
1Y Performance:
+0.00%
1-Day Range:
$0.587
$0.61
1-Week Range:
$0.58
$0.6426
52-Week Range:
$0.5103
$6.09
Autonomix Medical Inc Stock (AMIX) Company Profile
Name
Autonomix Medical Inc
Sector
Industry
Phone
832-277-7816
Address
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Autonomix Medical Inc Stock (AMIX) Latest News
Autonomix Flat on Unveiling Corner Segment - Baystreet.ca
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment - GlobeNewswire
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment - Yahoo Finance
Potential Price Increase for Vor Biopharma Inc (VOR) After Recent Insider Activity - Knox Daily
VOR’s Stock Market Adventure: -65.78% YTD Growth Amidst Volatility - The InvestChronicle
Investing in Vor Biopharma Inc (VOR) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Market Resilience: Vor Biopharma Inc (VOR) Finishes Weak at 0.83, Down -7.78 - The Dwinnex
Stock hits 5% upper circuit after Motilal Oswal Mutual Fund bought 2.12% stake - Trade Brains
Motilal Oswal MF buys 2% in smallcap stock that is up 1,515% in 16 months - Business Standard
Autonomix Medical faces potential Nasdaq delisting - Investing.com
Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum - GlobeNewswire
Market Resilience: Vor Biopharma Inc (VOR) Finishes Weak at 0.93, Down -2.48 - The Dwinnex
Vor Biopharma Inc (VOR) requires closer examination - US Post News
Moove, Rappi edge closer to IPOs - LatinFinance
Ladenburg Thalmann Initiates Coverage of Autonomix Medical (AMIX) with Buy Recommendation - MSN
Autonomix rises after it reports reduction of pain in pancreatic cancer treatment - MSN
Autonomix reports pain relief in pancreatic cancer trial - Investing.com India
Autonomix reports pain relief in pancreatic cancer trial - Investing.com
Autonomix reports pain relief in pancreatic cancer trial By Investing.com - Investing.com Canada
Autonomix reports pain reduction in pancreatic cancer patient treatment - TipRanks
Autonomix reports pain relief in pancreatic cancer trial By Investing.com - Investing.com UK
Autonomix Medical (AMIX) Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients - StreetInsider.com
Autonomix Announces 83% Reduction of Pain at 4-6 Week - GlobeNewswire
Autonomix Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients - Quantisnow
Market cap of Autonomix Medical Inc. [AMIX] reaches 20.09M – now what? - The DBT News
Take off with Autonomix Medical Inc. (AMIX): Get ready for trading - SETE News
Ratio Analysis: Unpacking Autonomix Medical Inc. (AMIX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Autonomix Medical (NASDAQ:AMIX) Now Covered by Analysts at LADENBURG THALM/SH SH - Defense World
Autonomix initiated with a Buy at Ladenburg - TipRanks
Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance
Metric Deep Dive: Understanding Autonomix Medical Inc. (AMIX) Through its Ratios - The Dwinnex
Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress - GlobeNewswire
Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress - Yahoo Finance
AMIX Stock Earnings: Autonomix Medical Reported Results for Q1 2025 - InvestorPlace
Autonomix targets first half of 2025 for topline data from proof-of-concept study - Medical Device Network
Autonomix targets first half of 2025 for topline data from proof-of-concept study - Clinical Trials Arena
Autonomix targets first half of 2025 for topline data from proof-of-concept study - Yahoo Finance
Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones - BioSpace
Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones - GlobeNewswire
Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones - Yahoo Finance
A new trading data show Autonomix Medical Inc. (AMIX) is showing positive returns. - SETE News
Trading Day Triumph: Autonomix Medical Inc. (AMIX) Ends at 0.79, a -23.30 Surge/Plunge - The Dwinnex
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment - StockTitan
Nothing is Better Than Autonomix Medical Inc. (AMIX) stock at the moment - SETE News
Closing Bell Recap: Autonomix Medical Inc. (AMIX) Ends at 1.29, Reflecting a 8.40 Upturn - The Dwinnex
Autonomix Medical Inc. (AMIX) Stock: A Year of Declines and Increases - The InvestChronicle
Head-To-Head Review: Motus GI (NASDAQ:MOTS) versus Autonomix Medical (NASDAQ:AMIX) - Defense World
Autonomix completes licensing transaction for FDA-cleared ablation technology - TipRanks
Prepare Yourself for Liftoff: Autonomix Medical Inc. (AMIX) - SETE News
Trading Day Review: Autonomix Medical Inc. (AMIX) Loses Momentum, Closing at 1.19 - The Dwinnex
Autonomix Medical Inc Stock (AMIX) Financials Data
There is no financial data for Autonomix Medical Inc (AMIX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.25%
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):